Rare diseases
Investigational molecules
Locations
Back to Greece1 008 clinical trials in Chaidari, Greece across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GreeceΚλινικεσΔοκιμεσ.gr(opens in a new tab)Study on Baxdrostat and Dapagliflozin for Adults with Chronic Kidney Disease and High Blood Pressure
GreeceStudy on the Effects of Guselkumab and Golimumab for Patients with Moderate to Severe Ulcerative Colitis
GreeceStudy of Tucatinib, Trastuzumab, and mFOLFOX6 for Patients with HER2+ Metastatic Colorectal Cancer
GreeceStudy on the Safety of Salbutamol Inhalers with Propellants HFA-152a and HFA-134a for Adults with Asthma
GreeceStudy on the Effects of Budesonide, Glycopyrronium, and Formoterol Fumarate for Patients with Chronic Obstructive Pulmonary Disease (COPD)
GreeceStudy on Long-Term Safety of Iclepertin for Patients with Schizophrenia Who Completed Previous Trials
GreeceStudy on the Effects of Fipaxalparant in Patients with Diffuse Cutaneous Systemic Sclerosis
GreeceStudy of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease
GreeceStudy on Amlitelimab for Patients Aged 12 and Older with Moderate-to-Severe Atopic Dermatitis
GreeceStudy on Long-Term Safety of GSK1070806 for Patients with Moderate to Severe Atopic Dermatitis
GreeceStudy of Adagrasib with Pembrolizumab and Chemotherapy for Patients with Advanced Non-Small Cell Lung Cancer with KRAS G12C Mutation
GreeceStudy on Asundexian for Preventing Ischemic Stroke in Adults After a Stroke or High-Risk Mini-Stroke
GreeceThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical research focusing on squamous cell carcinoma of the head and neck, exploring combination therapy approaches that integrate immunotherapy with traditional treatments.
The study evaluates the effectiveness of combining nivolumab with standard cisplatin-radiotherapy, aiming to improve disease-free survival rates in patients with resected head and neck cancer.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
